Stocktoria
Oncology Institute, Inc. TOI
Nasdaq · XNAS · stock · Services-Offices & Clinics of Doctors of Medicine · website · IPO 2020-03-13
Oncology Institute, Inc. statistics & valuation
Market cap$538.9M
P / S1.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -7.2% | -15.3% | -23.8% | -32.5% | -22.6% |
| Net margin | -12.1% | -16.4% | -25.6% | 0.1% | -5.4% |
| FCF margin | -5.5% | -7.7% | -12.6% | -26.6% | -17.5% |
| Return on assets | -36.8% | -37.4% | -39.7% | 0.1% | -5.4% |
| Return on equity | 385.5% | -1801.7% | -145.7% | 0.1% | -10.5% |
| Debt / equity | -4.92× | 25.95× | 1.52× | 0.65× | 0.00× |
| Current ratio | 1.59 | 2.15 | 4.12 | 4.39 | 5.17 |
| Revenue growth | 27.8% | 21.3% | 28.4% | 24.4% | 8.3% |
Source: SEC EDGAR filings · CIK 0001799191 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.